↓ Skip to main content

Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

Overview of attention for article published in Breast Cancer Research, May 2020
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
8 Mendeley